Fabio Costa1, Enzo Emanuelli2, Leonardo Franz3, Alessandro Tel4, Salvatore Sembronio5, Massimo Robiony6. 1. Maxillofacial Surgery Unit, Azienda Ospedaliero Universitaria of Udine, Udine, Italy. Electronic address: drfabiocosta@libero.it. 2. Department of Otorhinolaryngology and Otologic Surgery, Azienda Ospedaliera - Policlinico of Padova, Padova, Italy. 3. Azienda Ospedaliera - Policlinico of Padova, Padova, Italy. 4. Azienda Ospedaliero Universitaria of Udine, Udine, Italy. 5. Maxillofacial Surgery Unit, Azienda Ospedaliero Universitaria of Udine, Udine, Italy. 6. Azienda Ospedaliero Universitaria of Udine, Department of Medical and Biological Science, University of Udine, Udine, Italy.
Abstract
BACKGROUND: Maxillary fungus ball (FB) is the most frequent paranasal localization. OBJECTIVE: To review clinical presentation, surgery and results of treatment in our series of patients with maxillary FB. To review the literature concerning treatment of maxillary FB. PATIENTS AND METHODS: 48 patients with a diagnosis of maxillary FB were treated with endoscopic sinus surgery (ESS) alone or in association with external approaches. Before surgery all patients received computed tomography (CT), nasal endoscopy and dental examination. All the patients were followed for 1 year after surgery. Studies concerning surgical treatment of maxillary FB from 2006 were reviewed. RESULTS: The mean age of patients was 53.6 ± 11.9 years. 20 patients (41.6%) did not present any symptom, 19 patients (39.7%) had nasal symptoms, 3 patients (6.2%) had facial pain, 6 patients (12.5%) had a combination of both. Endoscopic examination was positive in 31 patients (64.6%), 17 patients (35.4%) showed negative findings. Logit regression model demonstrated that clinical symptoms contribute to the prediction of a positive endoscopic examination. 25 patients (52.1%) presented odontogenic factors. Complete clinical and radiological resolution of FB was observed in 46 patients (95.8%). CONCLUSIONS: Comparing our sample to the studies reviewed we may concluded that odontogenic factors were frequently reported and should be treated at the same time of maxillary FB. ESS alone or in association with external approaches is an effective treatment for patients with maxillary FB.
BACKGROUND: Maxillary fungus ball (FB) is the most frequent paranasal localization. OBJECTIVE: To review clinical presentation, surgery and results of treatment in our series of patients with maxillary FB. To review the literature concerning treatment of maxillary FB. PATIENTS AND METHODS: 48 patients with a diagnosis of maxillary FB were treated with endoscopic sinus surgery (ESS) alone or in association with external approaches. Before surgery all patients received computed tomography (CT), nasal endoscopy and dental examination. All the patients were followed for 1 year after surgery. Studies concerning surgical treatment of maxillary FB from 2006 were reviewed. RESULTS: The mean age of patients was 53.6 ± 11.9 years. 20 patients (41.6%) did not present any symptom, 19 patients (39.7%) had nasal symptoms, 3 patients (6.2%) had facial pain, 6 patients (12.5%) had a combination of both. Endoscopic examination was positive in 31 patients (64.6%), 17 patients (35.4%) showed negative findings. Logit regression model demonstrated that clinical symptoms contribute to the prediction of a positive endoscopic examination. 25 patients (52.1%) presented odontogenic factors. Complete clinical and radiological resolution of FB was observed in 46 patients (95.8%). CONCLUSIONS: Comparing our sample to the studies reviewed we may concluded that odontogenic factors were frequently reported and should be treated at the same time of maxillary FB. ESS alone or in association with external approaches is an effective treatment for patients with maxillary FB.
Authors: Antonio M Bulfamante; Carlotta Pipolo; Umberto D'Agostino Fiorenza; Flavio Arnone; Paolo Lozza; Giovanni Felisati; Alberto Maria Saibene Journal: Clin Case Rep Date: 2020-12-14
Authors: Mohammed Basurrah; Do Hyun Kim; Il Hwan Lee; Sung Won Kim; Soo Whan Kim Journal: ORL J Otorhinolaryngol Relat Spec Date: 2021-10-06 Impact factor: 1.919